Clinical Trial Update: A Study of the Safety of Mibavademab in Pediatric and Adult Participants Switching From Metreleptin to Mibavademab for the Treatment of Generalized Lipodystrophy (GLD) [Phase 3]

View source ↗

Summary

Phase 3 study assessing the safety of switching from metreleptin to mibavademab in adults and children with Generalized lipodystrophy; the trial is currently ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Lipodystrophy

Drugs mentioned

• Metreleptin (metreleptin)
• Mibavademab

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Generalized Lipodystrophy | Phase 3 | Status: ACTIVE_NOT_RECRUITING